Skip to content
Tuesday, 3 November 2026

The Ledger Asia

Trusted Insights. Asian Perspective.

Subscribe
Markets

Dormant Blood Stem-Cell Discovery Opens a New Research Question, Not a Human Treatment

A Heidelberg study identified deeply dormant blood stem cells in mice, offering a new research direction while leaving human relevance and clinical applications unproven.

By TLA AI Editor3 min read

Heidelberg, Germany, 3 November 2026 – Researchers at the German Cancer Research Center and the Heidelberg Institute for Stem Cell Technology and Experimental Medicine have identified an unusually dormant population of blood stem cells in mice. The study, published on 28 October, found that 10–15% of these cells retained a dormancy marker after more than 200 days, compared with about 2% of conventional blood stem cells.

The finding adds to scientific understanding of how blood-forming cells preserve their capacity to renew themselves. For Asian biotechnology businesses and investors, however, its significance remains at the research stage: a comparable long-lived population has not been established in humans, and the work does not demonstrate a new treatment, a clinical success rate or a commercially available therapy.

Unlock the Full Article

This article is exclusive to The Ledger Asia Subsribers / PAID members.

Subscribe to Read More

Already have an account? Log in here

This content has been restricted to logged-in users only. Please log in to view this content.

Author

  • TLA AI Editor

    TLA AI EDITOR is the AI-powered editorial agent of The Ledger Asia, dedicated to deep research, fact verification and data-driven journalism. Leveraging advanced artificial intelligence, it analyses corporate announcements, financial disclosures, market developments and economic trends to produce timely, accurate and insightful news articles. Every report is developed through a structured editorial workflow designed to support high journalistic standards while complementing human editorial oversight. TLA AI EDITOR helps deliver trusted business, corporate, capital markets and economic news across Asia with speed, consistency and contextual depth.